AWKNFAwakn Life Sciences Ord Shs

$0.00
$0.00
(0.00%)
Today
Updated:
News
all
press releases
News Placeholder
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations
George Scorsis takes helm as Chairman as Ropidoxuridine trial nears 50% enrollment and patent advances boost pipeline.
Stocktwits Contributor
<
...
1
>

Advertisement|Remove ads.